UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent

Proceedings of the National Academy of Sciences - PNAS, 2013-08, Vol.110 (32), p.E2987-E2996

2013

Volltextzugriff (PDF)

Auristatin Antibody Drug Conjugate Physical Instability and the Role of Drug Payload

Bioconjugate chemistry, 2014-04, Vol.25 (4), p.656-664

2014

Volltextzugriff (PDF)

Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index

Nature biotechnology, 2008-08, Vol.26 (8), p.925-932

2008

Volltextzugriff (PDF)

Development of poly-( d, l-lactide–coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis

Journal of controlled release, 2001-05, Vol.72 (1), p.13-24

2001

Volltextzugriff (PDF)

Encapsulation and stabilization of nerve growth factor into poly(lactic‐co‐glycolic) acid microspheres

Journal of pharmaceutical sciences, 2001-09, Vol.90 (9), p.1356-1365

2001

Volltextzugriff (PDF)

Intracranial delivery of recombinant nerve growth factor : Release kinetics and protein distribution for three delivery systems

Pharmaceutical research, 1999-02, Vol.16 (2), p.232-240

1999

Volltextzugriff (PDF)

Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes

Journal of controlled release, 2000-07, Vol.67 (2), p.281-292

2000

Volltextzugriff (PDF)

C‑Terminal Lysine Processing of IgG in Human Suction Blister Fluid: Implications for Subcutaneous Administration

Molecular pharmaceutics, 2022-11, Vol.19 (11), p.4043-4054

2022

Volltextzugriff (PDF)

Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project

Nature biotechnology, 2008-08, Vol.26 (8), p.889-896

2008

Volltextzugriff (PDF)

In vivo characterization of sustained-release formulations of human growth hormone

The Journal of pharmacology and experimental therapeutics, 1997-06, Vol.281 (3), p.1431

1997

Volltextzugriff (PDF)

Evaluation of Heavy-Chain C-Terminal Deletion on Product Quality and Pharmacokinetics of Monoclonal Antibodies

Journal of pharmaceutical sciences, 2016-07, Vol.105 (7), p.2066-2072

2016

Volltextzugriff (PDF)

Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect

Journal of controlled release, 1997-12, Vol.49 (2), p.193-205

1997

Volltextzugriff (PDF)

Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent

Proceedings of the National Academy of Sciences - PNAS, 2013-08, Vol.110 (32), p.12865-12865

2013

Volltextzugriff (PDF)

A month-long effect from a single injection of microencapsulated human growth hormone

Nature medicine, 1996-07, Vol.2 (7), p.795-799

1996

Volltextzugriff (PDF)

The stabilization and encapsulation of human growth hormone into biodegradable microspheres

Pharmaceutical research, 1997-06, Vol.14 (6), p.730-735

1997

Volltextzugriff (PDF)

Comparison between light induced and chemically induced oxidation of rhVEGF

Pharmaceutical research, 2001-10, Vol.18 (10), p.1455-1460

2001

Volltextzugriff (PDF)

The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres

Pharmaceutical research, 1997-04, Vol.14 (4), p.420-425

1997

Volltextzugriff (PDF)

Intraocular pharmacokinetics and safety of a humanized monoclonal antibody in rabbits after intravitreal administration of a solution or a PLGA microsphere formulation

Toxicological sciences, 1999-11, Vol.52 (1), p.101-106

1999

Volltextzugriff (PDF)

Development of a single‐shot subunit vaccine for HIV‐1. 5. Programmable in vivo autoboost and long lasting neutralizing response

Journal of pharmaceutical sciences, 1998-12, Vol.87 (12), p.1489-1495

1998

Volltextzugriff (PDF)

Pharmacological modulation of the tissue response to implanted polylactic-co-glycolic acid microspheres

European journal of pharmaceutics and biopharmaceutics, 1997-07, Vol.44 (1), p.89-102

1997

Volltextzugriff (PDF)

Development of a single-shot subunit vaccine for HIV-1: Part 4. Optimizing microencapsulation and pulsatile release of MN rgp120 from biodegradable microspheres

Journal of controlled release, 1997-08, Vol.47 (2), p.135-150

1997

Volltextzugriff (PDF)

Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer

Breast (Edinburgh), 2024-08, Vol.76, p.103761, Article 103761

2024

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Life Sciences & Biomedicine
(19)
Animals
(13)
Biological And Medical Sciences
(13)
Pharmacology & Pharmacy
(13)
Medical Sciences
(12)
Pharmacology. Drug Treatments
(12)
Chemistry
(11)
Chemistry, Multidisciplinary
(11)
General Pharmacology
(11)
Physical Sciences
(11)
Microspheres
(10)
Humans
(9)
Pharmaceutical Technology. Pharmaceutical Industry
(9)
Male
(6)
Polylactic Acid-Polyglycolic Acid Copolymer
(6)
Rats
(6)
Drug Stability
(5)
Rats, Sprague-Dawley
(5)
Chromatography, Gel
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent

Auristatin Antibody Drug Conjugate Physical Instability and the Role of Drug Payload

Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index

Development of poly-( d, l-lactide–coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis

Encapsulation and stabilization of nerve growth factor into poly(lactic‐co‐glycolic) acid microspheres

Intracranial delivery of recombinant nerve growth factor : Release kinetics and protein distribution for three delivery systems

Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes

C‑Terminal Lysine Processing of IgG in Human Suction Blister Fluid: Implications for Subcutaneous Administration

Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project

In vivo characterization of sustained-release formulations of human growth hormone

Evaluation of Heavy-Chain C-Terminal Deletion on Product Quality and Pharmacokinetics of Monoclonal Antibodies

Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect

Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent

A month-long effect from a single injection of microencapsulated human growth hormone

The stabilization and encapsulation of human growth hormone into biodegradable microspheres

Comparison between light induced and chemically induced oxidation of rhVEGF

The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres

Intraocular pharmacokinetics and safety of a humanized monoclonal antibody in rabbits after intravitreal administration of a solution or a PLGA microsphere formulation

Development of a single‐shot subunit vaccine for HIV‐1. 5. Programmable in vivo autoboost and long lasting neutralizing response

Pharmacological modulation of the tissue response to implanted polylactic-co-glycolic acid microspheres

Development of a single-shot subunit vaccine for HIV-1: Part 4. Optimizing microencapsulation and pulsatile release of MN rgp120 from biodegradable microspheres

Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer

Suchergebnisse filtern